Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Cash & Current Investments (2019 - 2025)

Historic Cash & Current Investments for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to $639.4 million.

  • IDEAYA Biosciences' Cash & Current Investments fell 546.06% to $639.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $639.4 million, marking a year-over-year decrease of 546.06%. This contributed to the annual value of $639.4 million for FY2025, which is 546.06% down from last year.
  • According to the latest figures from Q4 2025, IDEAYA Biosciences' Cash & Current Investments is $639.4 million, which was down 546.06% from $786.9 million recorded in Q3 2025.
  • In the past 5 years, IDEAYA Biosciences' Cash & Current Investments ranged from a high of $920.0 million in Q3 2024 and a low of $246.8 million during Q4 2021
  • Over the past 5 years, IDEAYA Biosciences' median Cash & Current Investments value was $481.2 million (recorded in 2023), while the average stood at $498.6 million.
  • Per our database at Business Quant, IDEAYA Biosciences' Cash & Current Investments soared by 24408.23% in 2021 and then crashed by 1644.68% in 2022.
  • Quarter analysis of 5 years shows IDEAYA Biosciences' Cash & Current Investments stood at $246.8 million in 2021, then surged by 47.84% to $364.8 million in 2022, then skyrocketed by 43.93% to $525.1 million in 2023, then grew by 28.79% to $676.3 million in 2024, then dropped by 5.46% to $639.4 million in 2025.
  • Its last three reported values are $639.4 million in Q4 2025, $786.9 million for Q3 2025, and $669.7 million during Q2 2025.